SHARON STOBERT: Open Payments
NPI 1013133032 · CHESWICK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,461 in 164 payments from 23 companies in 2025. Trend: 2023 $3,674 · 2024 $3,566 · 2025 $3,461
Food & beverage: $3,361Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 23 | $491 |
| Novo Nordisk Inc | 23 | $459 |
| AstraZeneca Pharmaceuticals LP | 11 | $422 |
| ABBVIE INC. | 21 | $298 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $266 |
| Astellas Pharma US Inc | 5 | $201 |
| SHIELD THERAPEUTICS INC | 11 | $187 |
| Amgen Inc. | 10 | $177 |
| Lilly USA, LLC | 8 | $170 |
| Daiichi Sankyo Inc. | 5 | $111 |
Products named: TRELEGY ELLIPTA, BREZTRI, Wegovy, JARDIANCE, ACCRUFER, MOUNJARO, UBRELVY, OTEZLA.
Industry payments across PA — which companies pay providers there.
